TEXIPY

Serial Number 79426152
680

Registration Progress

Application Filed
Apr 24, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

TEXIPY

Basic Information

Serial Number
79426152
Filing Date
April 24, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
680
Status Date
Dec 15, 2025
Application
Pending
Classes
005

Rights Holder

TAIHO PHARMACEUTICAL CO., LTD.

03
Address
1-27 Kandanishiki-cho,
Chiyoda-ku Tokyo 101-8444
JP

Ownership History

TAIHO PHARMACEUTICAL CO., LTD.

Original Applicant
03
JP

Legal Representation

Attorney
Norm J. Rich

Application History

14 events
Date Code Type Description Documents
Dec 15, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 30, 2025 RFNT P REFUSAL PROCESSED BY IB Loading...
Nov 20, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 20, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 20, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 9, 2025 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Nov 9, 2025 RFRR P REFUSAL PROCESSED BY MPU Loading...
Sep 23, 2025 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Sep 22, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 15, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 27, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 27, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 24, 2025 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Jun 19, 2025 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment, namely suppression, of tumors; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology, namely, for the treatment of cancers; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immune diseases and disorders; pharmaceutical preparations and substances in the nature of immunomodulators; pharmaceutical preparations and substances in the nature of immunosuppressive agents; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations in the nature of anti-inflammatory preparations; chemical reagents for medical purposes in the field of oncology

Classification

International Classes
005